Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Neurosci ; 16(4): 464-72, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23502536

ABSTRACT

The causes of major depression remain unknown. Antidepressants elevate concentrations of monoamines, particularly serotonin, but it remains uncertain which downstream events are critical to their therapeutic effects. We found that endogenous serotonin selectively potentiated excitatory synapses formed by the temporoammonic pathway with CA1 pyramidal cells via activation of serotonin receptors (5-HT(1B)Rs), without affecting nearby Schaffer collateral synapses. This potentiation was expressed postsynaptically by AMPA-type glutamate receptors and required calmodulin-dependent protein kinase-mediated phosphorylation of GluA1 subunits. Because they share common expression mechanisms, long-term potentiation and serotonin-induced potentiation occluded each other. Long-term consolidation of spatial learning, a function of temporoammonic-CA1 synapses, was enhanced by 5-HT(1B)R antagonists. Serotonin-induced potentiation was quantitatively and qualitatively altered in a rat model of depression, restored by chronic antidepressants, and required for the ability of chronic antidepressants to reverse stress-induced anhedonia. Changes in serotonin-mediated potentiation, and its recovery by antidepressants, implicate excitatory synapses as a locus of plasticity in depression.


Subject(s)
Depression/metabolism , Disease Models, Animal , Excitatory Postsynaptic Potentials/physiology , Long-Term Potentiation/physiology , Serotonin/physiology , Synapses/metabolism , Animals , Antidepressive Agents/pharmacology , Antidepressive Agents/therapeutic use , Depression/drug therapy , Excitatory Postsynaptic Potentials/drug effects , Long-Term Potentiation/drug effects , Male , Mice , Mice, 129 Strain , Mice, Inbred C57BL , Random Allocation , Rats , Rats, Sprague-Dawley , Serotonin/deficiency , Serotonin 5-HT1 Receptor Antagonists/pharmacology , Serotonin 5-HT1 Receptor Antagonists/therapeutic use , Synapses/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...